<?xml version="1.0" encoding="UTF-8"?>
<p>In total, 48% had complete neurophysiological studies for analysis. These revealed a predominance of AMAN compared to demyelinating subtype (
 <xref rid="pone.0230132.t007" ref-type="table">Table 7</xref>). Treatment was initiated with intravenous immunoglobulin in 68% and plasmapheresis in 20% (
 <xref rid="pone.0230132.t007" ref-type="table">Table 7</xref>). Mechanical ventilation was required in 12% of patients, and significantly more ZIKV-positive case-patients (diagnosed by PCR and at least one antecedent typical ZIKV symptom) required mechanical ventilation than ZIKV negative case-patients (OR: 13.67, 95% CI: 1.88â€“99.35). There was one in-hospital death after a long stay in the intensive care unit.
</p>
